BioCentury
ARTICLE | Clinical News

Zila Pharmaceuticals Inc. regulatory update

May 10, 1993 7:00 AM UTC

Zila Pharmaceuticals Inc. Zila Pharmaceuticals Inc., a division of Zila Inc. (ZILA), said that regulatory authorities in Australia have approved the marketing of OraScan, an oral cancer diagnostic a...